AbQader Bedil: Donor Ferritin Testing and Iron Care
AbQader Bedil, Medical Laboratory Technologist at French Medical Institute for Mothers and Children- FMIC, Laboratory Incharge at Stanikza Diagnostic clinic, shared a post on LinkedIn:
”Donor Ferritin Testing and Iron Care
Blood donation is generous — but repeated donations quietly drain iron stores. Measuring serum ferritin (not just hemoglobin) is the fastest way to spot iron depletion and act before donors develop symptoms or get deferred. Practical ferritin programs now show you can protect donors and keep the supply stable.
Quick facts:
- Many blood operators now add selective or routine ferritin testing to their donor-wellness programs to identify donors at risk of iron deficiency.
- Expert reviews and working groups recommend ferritin-guided policies (testing, tailored donation intervals, and iron supplementation) as the best way to prevent iron depletion in frequent donors.
- Recent trials show ferritin-guided donation intervals or ferritin-based supplementation significantly raise donors’ ferritin and hemoglobin and reduce iron-deferral rates.
What a practical ferritin program looks like:
- Decide scope: pilot high-risk groups first (premenopausal females, young donors, repeat donors), then expand if capacity allows.
- Pick action thresholds: many programs flag ferritin ≲25 µg/L for intervention (deferred interval or iron offer), but define locally with lab vendors and clinical leads.
- Define actions: short donor pause (eg, 3–6 months), offer oral iron with instructions, or schedule follow-up ferritin testing. Put the action in SOPs and donor letters.
- Measure outcomes: track percent low-ferritin donors, donor return rates, iron-related deferrals, and the program’s effect on supply — iterate from data.
Why this matters:
Ferritin testing is donor-centred and evidence-based: it prevents iron deficiency, reduces unexpected deferrals, and keeps more healthy donors in the pool — that’s a win for donors and patients.”
Stay updated with Hemostasis Today.
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden
-
May 27, 2026, 16:00Revealing Critical Gaps in Hemophilia Diagnosis and Access to Care in India – WFH
-
May 27, 2026, 16:00Melissa Hollo: Women Deserve Proactive Care, Not Reactive Care
-
May 27, 2026, 15:59Piotr Czempik: First Report of ROTEM Findings in Triple-Positive APS and Hageman Anomaly
-
May 27, 2026, 15:59Sara Trompeter: Improving Transfusion Safety Through Advanced Blood Matching in SCD
-
May 27, 2026, 15:58Hassan Raza: Global Advocacy for People With Bleeding Disorders Must Continue Beyond Adoption